TFO Wealth Partners LLC Boosts Stock Position in Bath & Body Works, Inc. (NYSE:BBWI) (2024)

Posted by Defense World Staff on Jun 6th, 2024

TFO Wealth Partners LLC boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 9,664.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,660 shares of the company’s stock after purchasing an additional 1,643 shares during the quarter. TFO Wealth Partners LLC’s holdings in Bath & Body Works were worth $72,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of BBWI. Oppenheimer Asset Management Inc. bought a new stake in shares of Bath & Body Works in the 3rd quarter valued at approximately $1,550,000. New York Life Investment Management LLC increased its position in Bath & Body Works by 30.3% during the third quarter. New York Life Investment Management LLC now owns 56,338 shares of the company’s stock valued at $1,904,000 after acquiring an additional 13,091 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Bath & Body Works by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,925,647 shares of the company’s stock valued at $65,087,000 after acquiring an additional 27,627 shares during the period. Shell Asset Management Co. lifted its holdings in shares of Bath & Body Works by 180.0% in the 3rd quarter. Shell Asset Management Co. now owns 56,344 shares of the company’s stock worth $1,904,000 after acquiring an additional 36,222 shares during the last quarter. Finally, Van ECK Associates Corp boosted its stake in shares of Bath & Body Works by 81.8% during the 3rd quarter. Van ECK Associates Corp now owns 87,836 shares of the company’s stock worth $2,969,000 after purchasing an additional 39,522 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Up 4.5 %

Shares of NYSE:BBWI opened at $47.22 on Thursday. The company has a market capitalization of $10.56 billion, a PE ratio of 12.17, a P/E/G ratio of 1.48 and a beta of 1.90. Bath & Body Works, Inc. has a 12-month low of $27.30 and a 12-month high of $52.99. The business’s fifty day simple moving average is $47.17 and its 200-day simple moving average is $44.05.

Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Tuesday, June 4th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.05. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.37 billion. Bath & Body Works had a negative return on equity of 40.00% and a net margin of 11.92%. The firm’s quarterly revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.33 earnings per share. Research analysts predict that Bath & Body Works, Inc. will post 3.27 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, June 7th. This represents a $0.80 dividend on an annualized basis and a yield of 1.69%. Bath & Body Works’s payout ratio is 20.62%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Wells Fargo & Company raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. BMO Capital Markets upped their price objective on Bath & Body Works from $50.00 to $55.00 and gave the company an “outperform” rating in a research report on Wednesday. UBS Group lifted their target price on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, The Goldman Sachs Group upped their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, March 4th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $48.53.

Read Our Latest Research Report on Bath & Body Works

Insider Buying and Selling at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is owned by insiders.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

You might be interested in:

The Manufacturers Life Insurance Company Lowers Position in Guardant Health, Inc.